1. Home
  2. PYXS vs MCHX Comparison

PYXS vs MCHX Comparison

Compare PYXS & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • MCHX
  • Stock Information
  • Founded
  • PYXS 2018
  • MCHX 2003
  • Country
  • PYXS United States
  • MCHX United States
  • Employees
  • PYXS N/A
  • MCHX N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • MCHX Business Services
  • Sector
  • PYXS Health Care
  • MCHX Consumer Discretionary
  • Exchange
  • PYXS Nasdaq
  • MCHX Nasdaq
  • Market Cap
  • PYXS 76.1M
  • MCHX 84.3M
  • IPO Year
  • PYXS 2021
  • MCHX 2004
  • Fundamental
  • Price
  • PYXS $1.28
  • MCHX $1.97
  • Analyst Decision
  • PYXS Strong Buy
  • MCHX
  • Analyst Count
  • PYXS 6
  • MCHX 0
  • Target Price
  • PYXS $9.20
  • MCHX N/A
  • AVG Volume (30 Days)
  • PYXS 551.2K
  • MCHX 43.5K
  • Earning Date
  • PYXS 03-20-2025
  • MCHX 03-13-2025
  • Dividend Yield
  • PYXS N/A
  • MCHX N/A
  • EPS Growth
  • PYXS N/A
  • MCHX N/A
  • EPS
  • PYXS N/A
  • MCHX N/A
  • Revenue
  • PYXS $16,146,000.00
  • MCHX $48,594,000.00
  • Revenue This Year
  • PYXS N/A
  • MCHX N/A
  • Revenue Next Year
  • PYXS N/A
  • MCHX $4.63
  • P/E Ratio
  • PYXS N/A
  • MCHX N/A
  • Revenue Growth
  • PYXS N/A
  • MCHX N/A
  • 52 Week Low
  • PYXS $1.23
  • MCHX $1.11
  • 52 Week High
  • PYXS $6.85
  • MCHX $2.40
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 32.91
  • MCHX 49.04
  • Support Level
  • PYXS $1.23
  • MCHX $1.92
  • Resistance Level
  • PYXS $1.40
  • MCHX $2.05
  • Average True Range (ATR)
  • PYXS 0.09
  • MCHX 0.10
  • MACD
  • PYXS 0.00
  • MCHX -0.00
  • Stochastic Oscillator
  • PYXS 15.15
  • MCHX 33.33

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

Share on Social Networks: